Related by context. All words. (Click for frequent words.) 59 Adentri 58 oxymorphone ER 57 BANZEL 57 Ticagrelor 56 extrapyramidal symptoms EPS 56 Octreolin 56 parecoxib 56 Liver toxicity 56 Xinlay 56 symptomatic NOH 55 cardiac toxicity 55 ATACAND 55 ACIPHEX 55 MEVACOR 55 cardiac repolarization 55 Peripheral edema 55 systemically absorbed 55 Quetiapine 54 SILENOR ™ 54 VIIBRYD 54 oral mTOR inhibitor 54 ACAPODENE 54 HMG CoA reductase inhibitors 54 extrapyramidal symptoms 54 QTc intervals 54 Fibrillex TM 54 Telintra 54 MICARDIS ® 54 ARCOXIA 54 NSAIDs aspirin 54 clazosentan 53 Itopride 53 torsemide ER 53 dopaminergic therapy 53 Entereg R 53 renal toxicity 53 intravenous bisphosphonates 53 elotuzumab 53 tanespimycin 53 CIMZIA TM certolizumab pegol 53 alpha interferons 53 NAbs 53 INTEGRILIN 53 tesofensine 53 sotalol 53 QT prolongation 53 ACCORD Lipid 53 non selective NSAIDs 53 AVANDIA 53 lenalidomide dexamethasone 53 Zelnorm Zelmac 53 pamidronate 53 treprostinil 53 cerebrovascular events 53 PITX2 methylation 53 paliperidone ER 53 APTIVUS r 53 Fablyn 52 LPM TM 52 antioxidant supplementation 52 glitazone class 52 adrenal suppression 52 approvability 52 lomitapide 52 simvastatin ezetimibe 52 REBETOL therapy 52 β blockers 52 TAXOTERE ® 52 hypercholesterolaemia 52 gemifloxacin 52 panitumumab Vectibix 52 SPARLON 52 supine hypertension 52 balsalazide 52 PLAVIX ® 52 nonvertebral fracture 52 nasopharyngitis headache 52 SSRI SNRI 52 ProSavin 52 oxycodone CR 52 EFFEXOR XR 51 COPD exacerbations 51 omecamtiv mecarbil 51 tapentadol ER 51 pulmonary exacerbations 51 ischemic cardiovascular 51 venlafaxine XR 51 refractory gout 51 GSK# [001] 51 triglyceride lowering 51 NNT = 51 ToGA 51 EDEMA3 trial 51 symptomatic hyponatremia 51 Aggrastat ® tirofiban hydrochloride 51 PegIFN RBV 51 postmarketing surveillance 51 Acapodene 51 myelosuppression 51 RAPTIVA R 51 INVEGA ™ 51 gastrointestinal ulcers 51 maximal doses 51 RAPTIVA 51 lacosamide 51 myopathy rhabdomyolysis 51 pemoline 51 headache nasopharyngitis 51 ticagrelor Brilinta 51 tegaserod 51 Torsades de Pointes 51 nociceptive pain 51 Pruvel 51 Entereg alvimopan 51 opioid mediated 50 TRADJENTA 50 TNF antagonist 50 Aloxi 50 Treatment discontinuations due 50 diarrhea vomiting nausea 50 RISPERDAL ® 50 KIACTA ™ 50 ALTACE 50 Bioaccelerate compounds under 50 benazepril 50 chronic idiopathic thrombocytopenic purpura 50 heterozygous FH 50 Bextra valdecoxib 50 desvenlafaxine succinate 50 oral antidiabetes 50 acitretin 50 hematological toxicity 50 parkinsonian symptoms 50 coinfected patients 50 efficacy endpoint 50 CIPN 50 5-fluorouracil/leucovorin 50 ARCALYST ® 50 cytopenias 50 unstable angina pectoris 50 Calcium intake 50 overlapping toxicities 50 Erythropoietic therapies may 50 HeFH 50 postoperative ileus POI 50 Anturol 50 unresectable HCC 50 secondary efficacy endpoint 50 urate lowering 50 QTc prolongation 50 exenatide LAR 50 CRD5 50 Emend 49 R# #mg BID 49 antimetabolites 49 venous thromboembolic events 49 metformin accumulation 49 tardive dyskinesia TD 49 1mg dose 49 poststroke depression 49 interferon gamma 1b 49 β blocker 49 cardiotoxic 49 NLX P# 49 INVEGA ® 49 dysrhythmias 49 hypersensitivity allergic reactions 49 atypical femur fractures 49 Zyprexa LAI 49 RX ACCULINK 49 hematologic toxicity 49 Reclast Aclasta 49 naronapride 49 clinical endpoints 49 recurrent VTE 49 pharmacodynamic effects 49 treatment emergent hyperglycemia 49 phase IIb study 49 Prosaptide 49 neuropsychiatric symptoms 49 naproxen sodium 49 ACTOplus met XR 49 Tardive dyskinesia 49 genericization 49 Dendreon Provenge 49 cardiovascular thrombotic 49 hematologic abnormalities 49 didanosine associated 49 Ozurdex 49 Mepact 49 Pfizer respectfully disagrees 49 TEAEs 49 CLIRS 49 cardiac valvulopathy 49 prednisone prednisolone 49 Eloxatin ® 48 containing LABAs 48 Hepatotoxicity 48 MAXY alpha 48 isoproterenol 48 QT interval prolongation 48 Sandostatin LAR 48 Drospirenone 48 elevated IOP 48 Hypotension 48 ACUROX ® 48 hepatic toxicity 48 primidone 48 Gilenia 48 menstrual migraine 48 severe hypersensitivity reactions 48 RISPERDAL 48 lumiracoxib 48 elevated plasma concentrations 48 samalizumab 48 headache abdominal pain 48 INTEGRILIN ® 48 Daytrana TM 48 Fentanyl Taifun 48 BENICAR 48 Dextofisopam 48 immune reconstitution 48 neutropenia dehydration dyspnea 48 ocular adverse 48 KIACTA TM 48 event reporting Clintrace 48 KAPVAY ™ 48 cerebral ischemia 48 KIF6 carriers 48 APTIVUS ritonavir 48 CYP #A# 48 Mevacor OTC 48 TRISENOX 48 Serious ocular 48 CVD mortality 48 liposomal doxorubicin 48 hypercalcemia 48 atherosclerotic progression 48 inhaled iloprost 48 liver transaminases 48 torsade de pointes 48 retrograde ejaculation 48 Byetta LAR 48 aprepitant 48 FIRMAGON 48 strong CYP#A# inducers 48 gastrointestinal GI bleeding 47 hyperprolactinemia 47 conjugated equine estrogen 47 pharmacodynamic parameters 47 somnolence dizziness 47 Cylert 47 REMICADE ® 47 postoperative chemotherapy 47 thromboembolic events 47 AGGRASTAT ® tirofiban hydrochloride 47 hypercholesterolemic patients 47 nephrotoxicity 47 pyrexia mucositis sepsis febrile 47 NUEDEXTA 47 unmeasured confounding 47 Zavesca ® 47 durable remissions 47 hypoglycemic episodes 47 anaphylactic reactions bronchospasm 47 Vimpat 47 severe asthma exacerbations 47 inhaled anticholinergics 47 Stent thrombosis 47 Febrile neutropenia 47 vernakalant oral 47 Serious adverse reactions 47 prescription painkiller Vioxx 47 Auxilium anticipates 47 Severe hypersensitivity reactions 47 aplindore 47 activate telomerase 47 digoxin toxicity 47 EXJADE 47 macrovascular disease 47 KRAS status 47 Syndrome RLS 47 pivotal bioequivalence 47 Known hypersensitivity 47 thienopyridine 47 fibrotic disease 47 prolactin elevation 47 delayed CINV 47 nausea constipation 47 Testosterone deficiency 47 pill Qnexa 47 cetrorelix pamoate 47 hemorrhagic complications 47 Vertex telaprevir 47 peak plasma concentrations 47 prospectively stratified 47 donepezil Aricept 47 pulls Darvon painkiller 47 postoperative radiotherapy 47 dizziness somnolence 47 hepatotoxicity 47 Tasigna prolongs 47 DETROL LA 47 Dual Opioid 46 ALT flares 46 postoperative AF 46 hyperkalemia 46 hepatic insufficiency 46 Doxil ® 46 nausea dizziness vomiting 46 Fanapt 46 Angiotensin Therapeutic Vaccine 46 Hypocalcemia 46 Cannasat 46 venlafaxine ER 46 gastrointestinal bleeds 46 concomitant medications 46 diarrhea dyspepsia 46 salmeterol HFA MDI 46 FLECTOR ® Patch 46 potassium sparing diuretics 46 headache flushing 46 CT PET SPECT 46 hypoglycemic events 46 transaminase elevations 46 nonhematologic adverse reactions 46 peginterferon alfa 46 antiepileptic 46 Oral mucositis 46 receiving XGEVA 46 zileuton IV 46 acetaminophen paracetamol 46 opioid agonists 46 Lipobay 46 nonfatal MI 46 apneic episodes 46 Iluvien TM 46 Rezulin diabetes 46 warfarin therapy 46 APEX AMI trial 46 thromboembolic 46 chromium picolinate supplementation 46 bone marrow suppression 46 indiplon capsules 46 malignancy HCM 46 myocardial infarction stroke 46 PRAVACHOL R 46 KETEK 46 Abrupt withdrawal 46 ischemic complications 46 corticosteroid therapy 46 PTH1 46 TMP SMX 46 randomized Phase 2b 46 torsades de pointes 46 HPA axis suppression 46 KRAS mutant tumors 46 Serious Adverse Events 46 lactic acidosis 46 Rotarix ® 46 oral olanzapine 45 insulin sensitizing drug 45 bovine thrombin 45 PDE 5i 45 Serotonin syndrome 45 almorexant 45 reactogenicity 45 CONCERTA 45 severe exacerbations 45 CYP#D# genotype 45 Secondary endpoints 45 EEG abnormalities 45 PDE 5i medications 45 Pulminiq 45 Discontinuations 45 dermatologic reactions 45 MS spasticity 45 severe hypoglycaemia 45 gastrointestinal toxicities 45 linear pharmacokinetics 45 AVADO 45 recurrent DVT 45 serious cardiovascular thrombotic 45 pathologic fractures 45 MACUGEN 45 guggul 45 O PPDS 45 autoimmune reactions 45 recurrent ischemia 45 angioedema 45 Acurox 45 domperidone 45 thrombocytopenia neutropenia 45 ddI 45 Chronic sleep deprivation 45 potentially hepatotoxic 45 noncardiovascular mortality 45 postmarketing adverse 45 neurocognitive functioning 45 hematological adverse 45 AGGRASTAT R tirofiban hydrochloride 45 QTc interval 45 Severe infusion 45 nonfatal stroke 45 uncontrollable muscle spasms 45 Schering-Plough/Merck 45 Treatment emergent adverse 45 Heavy snorers 45 periprocedural 45 relapsed MCL 45 Frova 45 surrogate endpoint 45 unintentional ingestion 45 venous thromboembolic disease 45 cardiovascular ischemic 45 thrombo embolic 45 constipation nausea 45 oral levofloxacin 45 fluticasone salmeterol 45 arterial thromboembolic events 45 events ADEs 45 Exacerbations 45 antiseizure 45 CERVARIX 45 haematologic 45 Sandostatin LAR Depot 45 symptom exacerbation 45 abiraterone 45 Kamada AAT 45 iii Cubist 45 JZP 6 45 heparin induced thrombocytopenia 45 thrombotic events 45 EMPOWER pivotal trial 45 Gastrointestinal GI 45 beta carotene supplementation 45 recurrent ischemic 45 immunological reaction 45 neurologic outcomes 45 hepatic dysfunction 45 Chronic hepatitis C 45 atherosclerotic renal artery stenosis 45 midstage clinical trial 44 Immtech clinical trials 44 MAXALT 44 TOPAMAX ® 44 abrupt discontinuation 44 symptomatic paroxysmal AF 44 EMPOWER ™ 44 Hematologic 44 PREZISTA 44 EGFRIs 44 carotid endarterectomy CEA 44 Sirolimus eluting Coronary Stent 44 Neuroleptic Malignant Syndrome NMS 44 SIMPADICO 44 antiseizure medications 44 Phase IIb trials 44 Levadex 44 neurologic dysfunction 44 divalproex 44 perioperatively 44 Adverse effects 44 Phase IIb III 44 CA9 SCAN 44 thrombus aspiration 44 cutaneous lupus 44 Priligy 44 TNF blocker therapy 44 lidocaine hydrochloride monohydrate powder 44 jaw osteonecrosis 44 events TEAEs 44 intracranial hemorrhage ICH 44 Intravail R 44 extrapyramidal side 44 INKP 44 macrovascular 44 linaclotide treated 44 inflammatory biomarkers 44 confirmed thrombotic cardiovascular 44 Asentar TM 44 events SAEs 44 Vertebral fractures 44 adverse cytogenetics 44 haemorrhagic stroke 44 recurrent venous thromboembolism 44 neutropenia thrombocytopenia 44 activate AMPK 44 concomitant AEDs 44 peripheral sensory neuropathy 44 neuropsychiatric adverse 44 sideeffects 44 TMJD 44 discontinuations due 44 heart medication Coreg 44 overdosage 44 arbaclofen 44 Hematologic toxicity 44 ICD shocks 44 DSL.net s 44 Xeloda monotherapy 44 SJS TEN 44 AML MDS 44 SIRT1 activators 44 EMEND 44 naprosyn 44 tumor lysis syndrome 44 tumor histology 44 incidence ≥ 44 Magnesium deficiency 43 TDF FTC 43 BioSante licensees 43 visceral fat accumulation 43 Afinitor 43 impair fertility 43 Suicidal ideation 43 G6PD deficiency 43 sodium valproate 43 acquisitions divestitures joint ventures 43 Infusion Reactions Severe 43 dysmenorrhoea 43 amenorrhea 43 vasodilatory 43 powerful RocketStream Protocols 43 ViRexx 43 Discontinuation 43 SYN X 43 upper gastrointestinal bleeding 43 insomnia somnolence 43 recurrent genital herpes 43 del 5q MDS 43 duloxetine HCl 43 Celebrex arthritis 43 EMPOWER TM 43 Acurox r 43 neurohormonal 43 Adverse reactions 43 hypotensive 43 daytime somnolence 43 clinically meaningful differences 43 Carotid endarterectomy 43 constipating effects 43 bronchopulmonary dysplasia BPD 43 hypokalaemia 43 prolonged QT interval 43 selective agonists 43 BEXXAR Therapeutic Regimen 43 nausea vomiting constipation 43 hormone receptor negative 43 Crisa acquisition 43 anaphylactoid 43 events thrombocytopenia neutropenia 43 SHKPI 43 Sativex 43 HF hospitalization 43 Exjade 43 locoregional recurrence 43 SCENESSE R 43 hematologic adverse 43 arterial thromboembolic 43 vasogenic edema 43 MICARDIS 43 thrombotic thromboembolic complications 43 Primary endpoints 43 thromboembolism 43 intracerebral haemorrhage 43 syncope fainting 43 Ushercell 43 ventricular arrhythmia 43 anemia neutropenia 43 bone marrow fibrosis 43 levodopa induced 43 suboptimal adherence 43 CYP#C# genotype 43 vascular insufficiency 43 macrovascular complications 43 x fluctuating beryllium 43 bronchodilatory 43 Lipitor Norvasc 43 CV thrombotic 43 Peripheral neuropathies 43 event reporting Empirica 43 iodine uptake 42 Dr. Eichenfield 42 Retrograde ejaculation 42 ARESTIN ® 42 suggest Roche Invirase 42 nonaspirin 42 Airvana anticipates 42 ventricular fibrillation VF 42 assessing T DM1 42 endometrial hyperplasia 42 SoloPath 42 Merck Vioxx 42 midstage study 42 botulin based 42 candidate blinatumomab MT# 42 Sleep disturbances 42 oral iron chelator 42 chemotherapy induced neutropenia 42 embolic stroke 42 containing sibutramine 42 hypoglycaemic episodes 42 intracerebral hemorrhage 42 bladder contractions 42 electrolyte disturbances 42 ATHX 42 Gastroesophageal Reflux 42 headache nausea diarrhea 42 Neither MicroStockProfit.com nor 42 neuropsychiatric events 42 ALIMTA 42 pulmonary toxicity 42 cSSSIs 42 lipoprotein profiles 42 unmeasured confounders 42 inflammatory bowel disorder 42 angiogenic therapy 42 Alzhemed 42 ragweed allergic children 42 noncardiac chest pain 42 interstitial pneumonia 42 dermatologic toxicities 42 phototoxicity 42 clinicopathological features 42 QTinno TM 42 INCIVEK 42 Osteoporotic fractures 42 depression suicidality 42 intravitreal triamcinolone 42 ZYBRESTAT fosbretabulin 42 Shire plc Attention Deficit 42 limiting toxicity 42 SREs 42 Dyspepsia Tachycardia Myalgia etc. 42 somnolence sedation 42 HyACT 42 comorbid psychiatric 42 VIOXX Lawsuits 42 NeuroAid TM 42 prognostic indicators 42 strategic pharmacovigilance WebVDME 42 chronic pancreatitis CP 42 immune suppressive 42 dizziness drowsiness 42 sinus tachycardia 42 Vioxx arthritis 42 neuroleptic malignant syndrome 42 lightheadedness dizziness 42 Akt signaling 42 Critical limb ischemia 42 hepatic failure 42 behavioral disturbances 42 frequent awakenings 42 TranSwitch indebtedness 42 ALJ Initial Determination 42 postoperative bleeding 42 warfarin erythromycin 42 genotypic resistance 42 decompensated heart failure 42 Provenge prostate cancer 42 impaired cognition 42 omacetaxine mepesuccinate 42 metabolic acidosis 42 Toric ICL 42 containing abacavir 42 hypocalcemia 42 neutropenia febrile neutropenia 42 hypersensitivity reaction 42 GABRA2 gene 42 Subgroup analyzes 42 Trigger Relevant Expiry Required 42 hepatic adverse 42 Acute pancreatitis 42 maintaining cardiorespiratory fitness 42 diarrhea headache nausea 42 Shire Attention Deficit 42 RELIANT trial 42 receiving VELCADE 42 Menstrual migraines 42 maximal dose 41 PLAVIX R patent 41 BeaconEquity Research nor 41 patent expiries 41 cSSSI 41 TSX COM 41 Hepatic Impairment 41 neutropenic sepsis 41 Dr. Andreas Barner 41 atherothrombotic 41 Grazax 41 risks anduncertainties 41 rhythm disturbances 41 teratogenic effects 41 discontinuations 41 MUHC ensuring 41 teratogenic 41 inhibitory neurotransmitters 41 multi factorial diseases 41 platelet function 41 Sepracor anticipates 41 neutropenic patients 41 GeoVax vaccine 41 Phase III cSSSI 41 postprandial hyperglycemia 41 hypomagnesemia 41 mucosal inflammation 41 gastrointestinal perforation 41 deems immaterial 41 Cynosure anticipates 41 Bcr Abl mutations 41 TYSABRI treated 41 optic neuropathy NAION 41 Thrombocytopenia 41 SRBD 41 Primary biliary cirrhosis 41 fluid overload 41 thrombotic thrombocytopenic purpura TTP 41 Toprol XL 41 akathisia 41 Auxilium assessments 41 ClearPath HDR 41 Rexahn licensees 41 hypersensitivity reactions 41 multivariate adjustment 41 cerebral vasospasm 41 Rexahn actual 41 Dietary fats 41 residual confounding 41 interferon beta therapy 41 Prognostic factors 41 uncontrolled seizures 41 Biologics Licensing 41 recombinant PSMA vaccine 41 acute phosphate nephropathy 41 non selective serotonergic 41 myalgia arthralgia 41 GI bleeds 41 Sirtex 41 neurologic complications 41 graduation Andrea Falletti 41 ispinesib administered 41 macroburst Ciemnecki 41 cardiac conduction 41 SANCTURA SANCTURA XR VANTAS 41 antidepressant Seroxat 41 NNRTI resistance 41 Gastrointestinal GI perforation 41 diarrhea nausea vomiting 41 delayed gastric emptying 41 strategic pharmacovigilance Empirica 41 GEMZAR 41 monoclonal gammopathy 41 nonfatal cardiovascular 41 EGRIFTA ™ tesamorelin 41 RSD# IV 41 renal insufficiency 41 Sensorineural hearing loss 41 unfavorable cytogenetics 41 SCD HeFT 41 treatment emergent adverse 40 syncopal 40 capillary leak 40 tiotropium Spiriva 40 vivo coagulation 40 QT QTc interval 40 erythema redness 40 PROLARIS 40 amifampridine phosphate 40 Yasmin Yaz 40 ADCS CGIC 40 atherosclerotic cardiovascular 40 ischemic cerebrovascular 40 patriotism Gration 40 nocturnal hypoglycaemia 40 sensory neuropathy 40 stent thrombosis blood clots 40 adverse 40 blockbuster antidepressant Zoloft 40 severe hypoglycemia 40 myocardial oxygen 40 Sucampo Pharmaceuticals anticipates 40 pulmonary exacerbation 40 cadence regulatory approvals 40 Starent Networks anticipates 40 coronary revascularization procedures 40 Abdul Karim al Ouneizi 40 SAEs 40 generic Depakote 40 elevated bilirubin 40 causative pathogen 40 Rituxan infusion 40 radiographic outcomes 40 oral prednisolone 40 market fluctuations investee 40 Secondary endpoints included 40 thorough QT 40 inhaled tobramycin 40 GIK infusion 40 risksassociated 40 pulmonary infiltrates 40 hematological toxicities 40 GI perforation 40 curability 40 LIFO adjustments 40 Acute Radiation Syndrome ARS 40 Parent Lindiwe Mbambo 40 immunotoxicity 40 adjunctive 40 Xeomin 40 thrombolytic therapy 40 fatal myocardial infarction 40 decompensation 40 intradialytic hypotension IDH 40 platelet dysfunction 40 Rezulin 40 hematologic toxicities 40 MacroChem actual 40 paresthesias 40 Chase Kishner 40 leucopenia 40 Hormone receptor 40 EPODURE Biopump 40 headache arthralgia 40 ototoxic 40 neutropaenia 40 hepatocellular carcinoma liver 40 adjudicative proceeding 40 multiple sclerosis sufferers 40 nephrotoxic 40 CompuFlo 40 Thrombotic events 40 Lactic acidosis 40 arterial thrombotic 40 symptomatic hypotension 40 serious neuropsychiatric symptoms 40 formoterol LABA 40 FluCAM arm 40 Gardisil 40 Autochartist Team 40 Nick Nasad FXTimes View 40 inhospital mortality 40 electrolyte abnormalities 40 GISSI HF 40 myocardial viability 39 SIMPADICO trial 39 fulminant hepatitis 39 Metastatic colorectal cancer 39 cholecystitis 39 Neutropenia 39 debilitating neurodegenerative disorder 39 Mean Symptom Complex 39 Premature menopause 39 discomfort bloating 39 tamoxifen metabolism 39 lowering homocysteine 39 hormonal milieu 39 uncertaintiesthat 39 Iron deficiency anemia 39 Drugs Advisory 39 TNF alpha antagonists 39 KRAS mutation status 39 oral mucosa 39 fetal malformations 39 elevated ALT 39 Secondary endpoints include 39 experienced hypomagnesemia 39 subsidiary Ther Rx 39 Skin rashes 39 thinner struts 39 gout flare 39 valdecoxib Bextra 39 varicella infection 39 myelosuppressive chemotherapy 39 transdermal patch 39 forward lookingstatement 39 bargain Adgate 39 ECG abnormalities 39 asthma exacerbation 39 Farmstead Telephone 39 adverse perinatal 39 Untreated sleep apnea 39 ripeness doctrine 39 sulfonylurea medicine 39 Acneform rash occurred 39 patent expiry 39 Biegelsen wrote 39 Victoza ® 39 PressureWire 39 facial transplantation 39 wildfire MacCracken 39 contingent guaranties 39 including boxed WARNINGS 39 Wyeth Pondimin 39 EnteroMedics proprietary neuroblocking 39 Peptic ulcers 39 Sunesis clinical trials 39 NEUMUNE 39 non hematological toxicities 39 renal dysfunction acute renal 39 mucocutaneous reactions 39 sale THACs sale 39 pricing IMPAX 39 release omeprazole capsules 39 Dodge Nitro Dodge Ram 39 marketconditions 39 thrombosis blood clots 39 APOE genotype 39 resuscitated cardiac arrest 39 cervical cancer vaccine Cervarix 39 LAMICTAL 39 Alhem appeared 39 CYPHER SELECT TM 39 Merger Arb ETF 39 DLTs 39 imperil Rohde life 39 intraobserver 39 mania hypomania 39 Urodynamix breakthrough medical 39 severe hypoglycemic 39 bong scandalOlympic champion 39 tiny pteropod 39 Vasomedical enhanced 39 Observational studies 39 alglucosidase alfa 39 factors APPY 39 Disease ILD 39 achieving PASI 39 symptomatic pulmonary embolism 39 Vitamin D insufficiency 39 silent ischemia 39 postoperative infections 39 events AEs 39 vaccine Cervarix 39 immunosuppressant medication 39 Excess sodium 39 microtubule destabilizing agent 39 Discontinuations due 39 traumatic spinal cord 39 nocebo effect 39 FERC MPSC NRC 39 spokeswoman Sarah Alspach 39 chronic obstructive lung 39 multivariable adjustment 38 various prepetition liabilities 38 leukopenia 38 inhibit CYP#A# 38 Menveo 38 regarding Heska 38 esophageal perforation 38 preterm newborns 38 intravaginal ejaculatory latency 38 irreversible scarring 38 communicate differentiations effectively 38 pancytopenia 38 untreated OSA 38 Uncontrolled seizures 38 Natalie Compagni Portis 38 prognostically 38 acute ischemic 38 adjuvant cisplatin 38 Hypersensitivity reactions 38 Reye syndrome rare 38 HMPL 38 BioForce Nanosciences actual 38 symptom flare ups 38 hallucinations dyskinesia 38 Endogenous Cushing Syndrome 38 Vocus filings 38 uncertainties materialize Shire plc 38 Achilles tendon ruptures 38 Cell Pouch System 38 PGP Acquisition 38 neurocognitive outcomes 38 thrombocytopenia anemia 38 PREVACID 38 Diabetic Mellitus 38 histrelin manufacturing marketing 38 outside nongenetic factors 38 XYOTAX metabolism 38 prolonged cytopenias 38 Seroxat 38 serologically active patients 38 related hematological toxicity 38 hemorrhagic cystitis 38 nestin expression 38 undue prejudice 38 Frequent vociferous protests 38 factorsthat 38 adverse effects 38 receiving ISENTRESS 38 acquisitions mergers dispositions 38 fetal neurodevelopment 38 c Relates 38 theseforward looking 38 neutropenia anemia 38 Reglan metoclopramide 38 For Koch Beame 38 intestinal microflora